Merck. 2010. Provides New Funding to Fight HIV/AIDS in Botswana.” “Merck Merck. 2011. Policy Statement: Intellectual Property and Access to Medicines in “Public the Developing World.” Merck. 2014. “ACHAP.” enjamin Coriat, Yves Souteyrand, Tony Barnett, Jermoe Dumoulin, and Yves-Antoine Flori, eds. 2003. Economics of AIDS and Access to to HIV/AIDS Care in Paris: Collection Sciences Developing Countries: Issues and Challenges. Sociales et Sida. Themba. 2007. from Botswana and the African Comprehensive “Lessons HIV/AIDS Partnerships.” Moon, Suerie, Elodie Jambert, Michelle Childs, and Tido von Schoen-Angerer. 2011. win-win solution? A critical analysis of tiered pricing to improve access to “A medecines in developing countries.” 7:39. Globalization and Health: Moon, Suerie. 2013. the right of access to medicines: Implications of the “Respecting UN Guiding principles on business and human rights for the pharmaceutical industry.” 15:1, 32-43. Health and Human Rights: Moon, Suerie and Wolfgang Hein. 2013. Informal Norms in Global Governance: Human Rights, Intellectual Property Rules, and Access to Essential Medicines. Ashgate Publishing: Farnam. Mugyenyi, Peter, et al. 2006. up antiretroviral therapy: experience of the Joint “Scaling Clinical Research Centre access programme.” 1, Acta Academica Supplementum, pp. 216-40. Mutume, Gumisai. 2001. Activists March Against Pharmaceutical Companies.” “AIDS Third World Network. http://www.twnside.org.sg/title/against.htm. Nunn, Amy, Elize Fonseca, Francisco Bastos, Sofia Gruskin, Joshua Salomon. 2007. of Antiretroviral Drug Costs in Brazil in the Context of Free and “Evolution Universal Access to AIDS Treatment.” 4:11, 1804-17. PLoS Medicine,
Merck. 2010. “Merck Provides New Funding to Fight HIV/AIDS in Botswana.” Merck. 2011. “Public Policy Statement: Intellectual Property and Access to Medicines in the Developing World.” Merck. 2014. “ACHAP.” enjamin Coriat, Yves Souteyrand, Tony Barnett, Jermoe Dumoulin, and Yves-Antoine Flori, eds. 2003. Economics of AIDS and Access to to HIV/AIDS Care in Developing Countries: Issues and Challenges. Paris: Collection Sciences Sociales et Sida. Themba. 2007. “Lessons from Botswana and the African Comprehensive HIV/AIDS Partnerships.” Moon, Suerie, Elodie Jambert, Michelle Childs, and Tido von Schoen-Angerer. 2011. “A win-win solution? A critical analysis of tiered pricing to improve access to medecines in developing countries.” Globalization and Health: 7:39. Moon, Suerie. 2013. “Respecting the right of access to medicines: Implications of the UN Guiding principles on business and human rights for the pharmaceutical industry.” Health and Human Rights: 15:1, 32-43. Moon, Suerie and Wolfgang Hein. 2013. Informal Norms in Global Governance: Human Rights, Intellectual Property Rules, and Access to Essential Medicines. Ashgate Publishing: Farnam. Mugyenyi, Peter, et al. 2006. “Scaling up antiretroviral therapy: experience of the Joint Clinical Research Centre access programme.” Acta Academica Supplementum, 1, pp. 216-40. Mutume, Gumisai. 2001. “AIDS Activists March Against Pharmaceutical Companies.” Third World Network. http://www.twnside.org.sg/title/against.htm. Nunn, Amy, Elize Fonseca, Francisco Bastos, Sofia Gruskin, Joshua Salomon. 2007. “Evolution of Antiretroviral Drug Costs in Brazil in the Context of Free and Universal Access to AIDS Treatment.” PLoS Medicine, 4:11, 1804-17.
Creating_The_World_Market_for_Lifesaving_AIDS_Drugs.docx